- 2025-09-26 11:07XMD17-109 1435488-37-1
- 2025-09-26 11:07VX-11e 896720-20-0
- 2025-09-26 11:07Tizaterkib (hexanedioic acid) 2097416-93-6
- 2025-09-26 11:07Zipalertinib (TAS-6417) 1661854-97-2
- 2025-09-26 11:07TERT activator-1 666699-46-3
- 2025-09-26 11:07Avitinib (AC0010) maleate 1557268-88-8
- 2025-09-26 11:07Temuterkib (LY3214996) 1951483-29-6
- 2025-09-26 11:07Almonertinib (HS-10296) hydrochloride 2134096-03-8
- 2025-09-26 11:07TAT-MEK1 566872-16-0
- 2025-09-26 11:07Nazartinib mesylate (EGF81) 1508250-72-3
- 2025-09-26 11:07STE-MEK1(13) (Ste-MPKKKPTPIQLNP-NH₂; ERK Activation Inhibitor Peptide) 566872-15-9
- 2025-09-26 11:07Nazartinib S-enantiomer (EGF816) 1508256-20-9
- 2025-09-26 11:07SOS1 activator 2 2245237-54-9
- 2025-09-26 11:07Lavendustin A 125697-92-9
- 2025-09-26 11:06SHR2415 2494010-42-1
- 2025-09-26 11:06Rociletinib hydrobromide (CO1686; AVL301) 1446700-26-0
- 2025-09-26 11:06SHP2-IN-23 2415989-91-0
- 2025-09-26 11:06Allitinib tosylate 1050500-29-2
- 2025-09-26 11:06Serum thymic factor acetate 125117-65-9
- 2025-09-26 11:06Erlotinib mesylate 248594-19-6
